MedPath

广州白云山医药集团股份有限公司白云山化学制药厂

Ownership
-
Established
1988-05-10
Employees
-
Market Cap
-
Website
http://byspharm.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

Cefepime Dihydrochloride

Product Name
盐酸头孢吡肟
Approval Number
国药准字H20080008
Approval Date
Oct 9, 2021
NMPA

Erythromycin Estolate

Product Name
依托红霉素
Approval Number
国药准字H44024158
Approval Date
Oct 27, 2020
NMPA

Cefradine

Product Name
头孢拉定
Approval Number
国药准字H10973040
Approval Date
Oct 27, 2020
NMPA

Cefaclor

Product Name
头孢克洛
Approval Number
国药准字H10960224
Approval Date
Oct 20, 2020
NMPA

Cefpodoxime Proxetil

Product Name
头孢泊肟酯
Approval Number
国药准字H20050122
Approval Date
Sep 22, 2020
NMPA

Cefetamet Pivoxil Hydrochloride

Product Name
盐酸头孢他美酯
Approval Number
国药准字H20040093
Approval Date
Sep 3, 2020
NMPA

Ceftazidime

Product Name
头孢他啶
Approval Number
国药准字H20013357
Approval Date
Sep 3, 2020
NMPA

Cefradine

Product Name
头孢拉定
Approval Number
国药准字H10930148
Approval Date
Sep 3, 2020
NMPA

Ciprofloxacin Hydrochloride

Product Name
盐酸环丙沙星
Approval Number
国药准字H10920089
Approval Date
Sep 3, 2020
NMPA

Dapsone

Product Name
氨苯砜
Approval Number
国药准字H44020953
Approval Date
Sep 3, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.